Worth Asset Management LLC Has $445,000 Stock Position in SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.9% in the 1st quarter, HoldingsChannel reports. The fund owned 3,485 shares of the exchange traded fund’s stock after selling 23,187 shares during the period. Worth Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $445,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Banque Pictet & Cie SA raised its stake in shares of SPDR S&P Biotech ETF by 24.1% in the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock worth $7,910,000 after purchasing an additional 12,595 shares during the last quarter. Apella Capital LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $490,000. Keystone Investors PTE Ltd. purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $12,022,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in SPDR S&P Biotech ETF by 106.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after buying an additional 13,729 shares in the last quarter. Finally, Greystone Financial Group LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $658,000.

SPDR S&P Biotech ETF Trading Up 3.7%

NYSEARCA XBI opened at $145.86 on Tuesday. The business has a fifty day simple moving average of $133.84 and a 200 day simple moving average of $127.95. SPDR S&P Biotech ETF has a 12 month low of $80.90 and a 12 month high of $146.77. The firm has a market capitalization of $9.31 billion, a P/E ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.